• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Smart patch monitors blood, releases blood thinners to prevent clots

November 29, 2016 By Sarah Faulkner

Smart patch monitors blood, releases blood thinners to prevent clotsResearchers from the North Carolina State University and the University of North Carolina at Chapel Hill have developed a patch designed to monitor a patient’s blood and release blood-thinning drugs to prevent dangerous blood clots, or thrombosis. The team’s work was published in Advanced Materials.

When blood clots disrupt the flow of blood throughout the body, the result can cause pulmonary embolism, heart attack or stroke. Conventional treatment requires patients to regularly test their blood to ensure proper dosages of blood thinners such as Heparin.

If a patient uses too small a dose, it may not prevent a relapse of thrombosis. On the contrary, too large a dose can cause spontaneous hemorrhaging.

“Our goal was to generate a patch that can monitor a patient’s blood and release additional drugs when necessary; effectively, a self-regulating system,” co-corresponding author Zhen Gu said in prepared remarks.

The smart patch includes polymeric microneedles that are made up of hyaluronic acid and Heparin. The modified polymer is responsive to an enzyme, thrombin, that sparks clotting in the blood.

“The more thrombin there is in the bloodstream, the more Heparin is needed to reduce clotting,” co-lead author Yuqi Zhang explained. “So we created a disposable patch in which the more thrombin there is in the blood stream, the more Heparin is released.”

“We will further enhance the loading amount of drug in the patch. The amount of Heparin in a patch can be tailored to a patient’s specific needs and replaced daily, or less often, as needed,” co-lead author Jicheng Yu added. “But the amount of Heparin being released into the patient at any given moment will be determined by the thrombin levels in the patient’s blood.”

The team tested its smart patch using a mouse model in which subjects were injected with fatal doses of thrombin to initiate blood clotting in the lungs. In the 1st experiment, mice were either untreated, given a shot of the blood thinner Heparin or given the smart patch. The mice were injected with thrombin and 15 minutes after the injection, only the mice that were untreated died.

In the 2nd experiment, the thrombin was injected 6 hours after treatment with Heparin or the smart patch. After 15 minutes, all of the mice with the smart patch had survived and 80% of the mice that received Heparin had died.

“We’re excited about the possibility of using a closed-loop, self-regulating smart patch to help treat a condition that affects thousands of people every year, while hopefully also driving down treatment costs,” Gu said. “This paper represents a good first step, and we’re now looking for funding to perform additional preclinical testing.”

Filed Under: Drug-Device Combinations, Featured, Pharmaceuticals, Research & Development Tagged With: North Carolina State University, University of North Carolina at Chapel Hill

IN CASE YOU MISSED IT

  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • Sequel Med Tech expects full twiist launch in the fall
  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS